«We observed rapid and durable
protective immunity without adverse events, and so we think this candidate vaccine represents a promising strategy for the global fight against Zika virus,» said senior author Drew Weissman, MD, PhD, a professor of Infectious Disease at Penn. «We hope to start clinical trials in 12 to 18 months.»
Not exact matches
In order to achieve sustained
protective immunity against AIDS, a vaccination strategy inducing a balanced immune response
without an increase of CD4 + T helper cells must be developed (Journal of Virology).
Studies have shown that shelters take in a greater percentage than vet clinics of adult animals
without prior
protective immunity (either natural exposure or vaccination) against panleukopenia or parvovirus, and it is not unusual for adult animals to be affected during shelter outbreaks.